Lupin launches generic hypertension drug in US

Drugmaker Lupin has launched its Amlodipine and Valsartan tablets, used for treatment of hypertension, in the US market after getting approval from the American health regulator.
The US arm of the company, Lupin Pharmaceuticals Inc, has launched Amlodipine and Valsartan tablets in various strengths in the US market after getting final approval from the United States Food and Drug Administration (USFDA), Lupin said in a statement.
Lupin's Amlodipine and Valsartan tablets are indicated for the treatment of hypertension and to lower blood pressure and is the generic version of Novarts Pharmaceuticals Corporation's Exforge tablets.
As per IMS MAT sales data, Exforge tablets had US sales of USD 414.9 million.

With this approval, the Mumbai-based firm has received six abbreviated new drug approvals (ANDAs) in the last three months.
Lupin shares were trading at Rs 2,033 a piece on the BSE, up 1.29 per cent from its previous close.